Marek Wanior
Max Von Laue Str. 15
Frankfurt Am Main, HE 60438, Germany
Frankfurt Am Main, HE 60438, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core.
Journal: Journal of medicinal chemistry
Published: December 14, 2022
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells.
Journal: Neoplasia (New York, N.Y.)
Published: March 23, 2021
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy.
Journal: Oncogene
Published: November 23, 2020
Pan-SMARCA/PB1 Bromodomain Inhibitors and Their Role in Regulating Adipogenesis.
Journal: Journal of medicinal chemistry
Published: November 20, 2020
A Selective Modulator of Peroxisome Proliferator-Activated Receptor γ with an Unprecedented Binding Mode.
Journal: Journal of medicinal chemistry
Published: April 09, 2020
PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.
Journal: Nature chemical biology
Published: February 02, 2020
Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells.
Journal: Oncogene
Published: January 10, 2019
BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells.
Journal: Haematologica
Published: October 12, 2017
Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis.
Journal: Journal of medicinal chemistry
Published: September 13, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026